ACHE and Alzheimer disease: Molecular docking analysis (Table 5) clearly indicates that RES and AJM are excellent multi-target directed ligands capable of inhibiting Aβ42 aggregation and key enzymes implicated in AD such as AChE, BuChE, BACE-1, and MAO-B.